RA Capital Management, L.P. 13D and 13G filings for Solid Biosciences Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-21 4:15 pm Purchase | 2025-02-19 | 13D | Solid Biosciences Inc. SLDB | RA Capital Management, L.P. | 7,989,820 9.900% | 3,631,342 (+83.32%) | Filing |
| 2024-06-12 6:26 pm Purchase | 2024-06-11 | 13D | Solid Biosciences Inc. SLDB | RA Capital Management, L.P. | 4,358,478 11.300% | 9,650 (+0.22%) | Filing |
| 2024-01-11 5:24 pm Purchase | 2024-01-11 | 13D | Solid Biosciences Inc. SLDB | RA Capital Management, L.P. | 4,348,828 11.700% | 917,210 (+26.73%) | Filing |
| 2022-12-05 5:12 pm Purchase | 2022-12-02 | 13D | Solid Biosciences Inc. SLDB | RA Capital Management, L.P. | 3,431,618 17.570% | 2,601,760 (+313.52%) | Filing |
| 2022-10-04 5:14 pm Unchanged | 2022-09-29 | 13D | Solid Biosciences Inc. SLDB | RA Capital Management, L.P. | 829,858 11.010% | 0 (Unchanged) | Filing |
| 2022-09-06 4:50 pm Purchase | 2022-09-02 | 13D | Solid Biosciences Inc. SLDB | RA Capital Management, L.P. | 829,858 11.010% | 5,333 (+0.65%) | Filing |
| 2021-03-23 4:32 pm Purchase | 2009-02-28 | 13D | Solid Biosciences Inc. SLDB | RA Capital Management, L.P. | 824,525 11.600% | 159,420 (+23.97%) | Filing |
| 2020-12-16 5:24 pm Purchase | 2009-02-28 | 13D | Solid Biosciences Inc. SLDB | RA Capital Management, L.P. | 665,105 11.800% | 360,360 (+118.25%) | Filing |